-+ 0.00%
-+ 0.00%
-+ 0.00%

Bioxytran Delays Quarterly Report After Auditor Proposes Last-Minute Revisions

PUBT·11/16/2026 22:26:12
Listen to the news
Bioxytran Delays Quarterly Report After Auditor Proposes Last-Minute Revisions
  • Bioxytran delayed its Form 10-Q for the quarter ended September 30, 2026, according to a November 16 filing.
  • Limited accounting staff needed more time to incorporate significant last-minute disclosure revisions proposed by the independent auditor.
  • The narrative anticipates filing within 15 days of the deadline, while the checked certification commits to five calendar days.
  • No significant change in operating results from the year-earlier period is anticipated.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioxytran Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-052609), on November 16, 2026, and is solely responsible for the information contained therein.